AU2003227148A1 - Anti-ck18 monoclonal antibody and therapeutic and diagnostic uses thereof in cancer - Google Patents

Anti-ck18 monoclonal antibody and therapeutic and diagnostic uses thereof in cancer

Info

Publication number
AU2003227148A1
AU2003227148A1 AU2003227148A AU2003227148A AU2003227148A1 AU 2003227148 A1 AU2003227148 A1 AU 2003227148A1 AU 2003227148 A AU2003227148 A AU 2003227148A AU 2003227148 A AU2003227148 A AU 2003227148A AU 2003227148 A1 AU2003227148 A1 AU 2003227148A1
Authority
AU
Australia
Prior art keywords
cancer
therapeutic
monoclonal antibody
diagnostic uses
diagnostic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003227148A
Other versions
AU2003227148A8 (en
Inventor
Xiaobo Duan
Timothy C. Groves
David Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arius Research Inc
Original Assignee
Arius Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arius Research Inc filed Critical Arius Research Inc
Publication of AU2003227148A1 publication Critical patent/AU2003227148A1/en
Publication of AU2003227148A8 publication Critical patent/AU2003227148A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
AU2003227148A 2002-04-05 2003-04-07 Anti-ck18 monoclonal antibody and therapeutic and diagnostic uses thereof in cancer Abandoned AU2003227148A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37065902P 2002-04-05 2002-04-05
US60/370,659 2002-04-05
PCT/CA2003/000500 WO2003086456A2 (en) 2002-04-05 2003-04-07 Anti-ck18 monoclonal antibody and therapeutic and diagnostic uses thereof in cancer

Publications (2)

Publication Number Publication Date
AU2003227148A1 true AU2003227148A1 (en) 2003-10-27
AU2003227148A8 AU2003227148A8 (en) 2003-10-27

Family

ID=29250562

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003227148A Abandoned AU2003227148A1 (en) 2002-04-05 2003-04-07 Anti-ck18 monoclonal antibody and therapeutic and diagnostic uses thereof in cancer

Country Status (2)

Country Link
AU (1) AU2003227148A1 (en)
WO (1) WO2003086456A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7431923B2 (en) 2005-01-03 2008-10-07 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of CD63
US7009040B2 (en) * 2003-01-21 2006-03-07 Arius Research, Inc. Cancerous disease modifying antibodies
US7361343B2 (en) * 2003-01-21 2008-04-22 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of CD63
US7442777B2 (en) 2000-11-29 2008-10-28 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of CD63
US7534429B2 (en) 2000-11-29 2009-05-19 Hoffmann-La Roche Inc. Cytotoxicity mediation of cells evidencing surface expression of CD63
US7361342B2 (en) * 2003-01-21 2008-04-22 Arius Research Inc. Cancerous disease modifying antibodies
US7393531B2 (en) 2003-01-21 2008-07-01 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of MCSP
US7468254B2 (en) 2003-01-21 2008-12-23 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of MCSP
US7399835B2 (en) 2004-02-26 2008-07-15 Arius Research Inc. Cancerous disease modifying antibodies
US7452978B2 (en) * 2005-08-02 2008-11-18 Arius Research, Inc. Cancerous disease modifying antibodies
US7456258B2 (en) * 2005-08-02 2008-11-25 Arius Research, Inc. Cancerous disease modifying antibodies
US7456259B2 (en) * 2005-08-02 2008-11-25 Arius Research, Inc. Cancerous disease modifying antibodies
US7494648B2 (en) * 2005-08-02 2009-02-24 Hoffmann-La Roche Inc. Cancerous disease modifying antibodies
US7411046B2 (en) * 2005-08-02 2008-08-12 Arius Research Inc Cancerous disease modifying antibodies
US7452979B2 (en) * 2005-08-02 2008-11-18 Arius Research, Inc. Cancerous disease modifying antibodies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9500023L (en) * 1994-05-17 1995-11-18 Beki Ab Ways to detect cancer
US6180357B1 (en) * 1999-10-08 2001-01-30 Arius Research, Inc. Individualized patient-specific anti-cancer antibodies
WO2003057168A2 (en) * 2002-01-03 2003-07-17 The Scripps Research Institute Cancer-associated epitope

Also Published As

Publication number Publication date
WO2003086456A2 (en) 2003-10-23
AU2003227148A8 (en) 2003-10-27
WO2003086456A3 (en) 2003-12-04

Similar Documents

Publication Publication Date Title
TWI367102B (en) Therapeutic human anti-il-1r1 monoclonal antibody
EP2940044B8 (en) Anti-tnf alpha antibodies for use in therapy
HK1081448A1 (en) Bispecific anti-erb-b antibodies and their use in tumor therapy
AU2002338015A1 (en) Human CDR-grafted antibodies and antibody fragments thereof
EP1572131A4 (en) Antibody therapy
AU2003215460A1 (en) Cancer associated protein kinases and their uses
IL172242A0 (en) Antibodies specific for cancer associated antigen sm5-1 and uses thereof
AU2002308348A1 (en) Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
EP1558284A4 (en) Combination therapy with class iii anti-cea monoclonal antibodies and therapeutic agents
AU2003227148A1 (en) Anti-ck18 monoclonal antibody and therapeutic and diagnostic uses thereof in cancer
EP1835027A4 (en) Novel cancer antigen peptide and the use thereof
AU2003205913A1 (en) Materials and methods relating to cancer diagnosis
AU7676300A (en) Human anti-adipocyte monoclonal antibodies and their use
AU2002352170A1 (en) Anti-t cell immunotoxin fusion protein and its therapeutic use
AU2003255544A1 (en) Tumor specific oligosaccharide epitopes and use thereof
AU2003219093A1 (en) Anti-hpv-16 e7 antibodies and their use
AU2003227861A1 (en) Protein involved in cancer
SI1639013T1 (en) Pan-kir2dl NK-receptor antibodies and their use in diagnostic and therapy
AU2003245858A1 (en) Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases
AU2002346049A1 (en) Coactivators in the diagnosis and treatment of breast cancer
AU2003209459A1 (en) Protein-protein interactions in human tumours involving bcmp-7 and bcmp-11
AU2003291896A1 (en) Saponins and sapogenins for use in combination therapy for cancer
AU2003211292A1 (en) Monoclonal antibody against human hepatoma and use thereof
AU2002310470A1 (en) Use of ribonuclease l in diagnosis of cancer
AU2003270518A1 (en) Therapeutic anti-bgp(c-cam1) antibodies and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase